Company Ticker News March 19, 2022Blueprint Medicines (BPMC) Down 9.1% Since Last Earnings Report: Can It Rebound? 0 0 Share
Press Release March 9, 2022Blueprint Medicines to Showcase Broad Precision Therapy Pipeline at AACR Annual Meeting 2022 0 0 Share
Press Release March 5, 2022Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 0 0 Share
Press Release February 28, 2022Blueprint Medicines and Proteovant Therapeutics Announce Strategic Collaboration to Advance Novel Targeted Protein Degrader Therapies 0 0 Share
Company Ticker News February 17, 2022Blueprint Medicines' (BPMC) CEO Jeff Albers on Q4 2021 Results - Earnings Call Transcript 0 0 Share
Company Ticker News February 16, 2022Blueprint Medicines Reports Fourth Quarter and Full Year 2021 Results 0 0 Share
Company Ticker News February 16, 2022Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates 0 0 Share
Company Ticker News February 12, 2022Blueprint Medicines to Present at Upcoming Investor Conferences 0 0 Share
Press Release February 5, 2022Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 0 0 Share
